This content is in French.
Oral anticoagulants or warfarin in stroke prevention
28 février 2024
In this observational cohort study conducted in Denmark, Sweden, Norway and Finland, 26,883 patients treated with reduced-dose oral anticoagulants (dagibatran, rivaroxaban, apixaban) and 108,014 patients treated…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
: Flemming Skjøth et al. Comparative safety and effectiveness of reduced doses of direct acting oral anticoagulants for stroke prevention in atrial fibrillation. Am J Med. 2024 Feb 20:S0002-9343(24)00098-6.
View the source
